Bruce Riddle, PhD, MA, an instructor in epidemiology at Geisel, has received the Constance L. Percy Award for Distinguished Service from the North American Association of Central Cancer Registries (NAACCR), the umbrella organization of central registries in the U.S. and Canada.
Post Tagged with: "cancer"
Effective cervical cancer screening initiative by Dartmouth researchers in Honduras identifies different human papillomavirus types than those in the U.S.
Ilana Cass, MD, vice chair of Obstetrics & Gynecology (OB-GYN) at Cedars-Sinai Medical Center in Los Angeles and professor of OB-GYN at Cedars Sinai Medical Center and at the David Geffen School of Medicine at UCLA, has been appointed Chair of OB-GYN at the Geisel School of Medicine at Dartmouth and Dartmouth-Hitchcock.
Steven D. Leach, MD, director of the Dartmouth-Hitchcock Norris Cotton Cancer Center and the Preston T. and Virginia R. Kelsey Distinguished Chair in Cancer at the Geisel School of Medicine at Dartmouth, has been named a Fellow of the American Association for the Advancement of Science.
Geisel professor and surgeon Richard Barth, MD, teamed up with two Thayer engineers to dramatically improve the accuracy of breast cancer surgery.
A newly published collaborative national study finds that most women with two or three sites of cancer in a single breast can successfully complete breast conservation therapy rather than mastectomy.
Many discoveries now revolutionizing the prevention and treatment of cancer can be traced back to Dartmouth—including immunotherapies for solid tumors, the integration of palliative care with cancer care, and the identification of cancer risks from environmental toxins and behaviors.
Experiences such as working as a volunteer on medical mission trips to Honduras and practicing as an oncology nurse in Arizona helped Meghan Bullock ’20 decide that medical school was the right path for her.
Michael Sporn, MD, emeritus professor of pharmacology and toxicology, and medicine, is featured in Nature Index 2017 for his tremendous impact upon biomedical research and drug development.
Dartmouth-led research is in early phase drug discovery and finds promising therapeutic leads after targeting vulnerabilities in nervous system tumors, including glioblastoma.